The relationship between branched-chain amino acids and alpha-keto acids in blood in uremia.
Branched-chain alpha-keto acid (BCKA) supplements are used as a nitrogen-free source of branched-chain amino acids (BCAA) in patients with chronic renal failure. Their use is dependent on the freely reversible interconversion of BCKA and BCAA in muscle tissue. In a group of eight young adults on dialysis compared to 11 normal healthy adults, the ratios of the fasting plasma concentrations of leucine and isoleucine to their corresponding alpha-keto acids, alpha-keto isocaproic acid and alpha-keto-beta-methyl-eta-valeric acid, respectively, were significantly elevated. These ratios appear to be sensitive to changes in intracellular glutamate and pyruvate. The ratios increased in seven insulin-dependent diabetics following insulin withdrawal, a situation where intracellular glutamate is increased. The ratios decreased in six normal healthy adults in response to submaximal treadmill exercise, a situation where intracellular pyruvate is increased. The elevated BCAA/BCKA ratios in uremia could be a reflection of reduced peripheral glucose utilization. A consequence of this will be enhanced conversion of supplemented BCKA to their corresponding BCAA. The close association between muscle BCAA and glucose metabolism suggests that the timing of BCKA administration in relation to energy intake might prove important.
D000293:Adolescent; D000328:Adult; D000597:Amino Acids, Branched-Chain / Q000097:blood*; D005260:Female; D005971:Glutamates / Q000378:metabolism; D045782:Hemiterpenes; D006801:Humans; D007424:Intracellular Fluid / Q000378:metabolism; D007651:Keto Acids / Q000097:blood*; D008297:Male; D011773:Pyruvates / Q000378:metabolism; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000628:therapy
D000597:Amino Acids, Branched-Chain; D005971:Glutamates; D045782:Hemiterpenes; D007651:Keto Acids; D011773:Pyruvates; C016211:alpha-keto-beta-methylvaleric acid; C001505:alpha-ketoisovalerate; C013082:alpha-ketoisocaproic acid